Tactile Systems Technology Book Value 2011-2026 | TCMD

Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.

What is included in book value

Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.

Features of the metric

Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account.
Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market.
Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors.
Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.

Annual Book Value Tactile Systems Technology

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
219 M	217 M	194 M	121 M	128 M	125 M	113 M	89.3 M	72.8 M	59.6 M	27.3 M	24.7 M	22.2 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
219 M	22.2 M	109 M

Quarterly Book Value Tactile Systems Technology

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
205 M	195 M	206 M	217 M	208 M	201 M	193 M	194 M	183 M	159 M	156 M	121 M	114 M	-	115 M	128 M	132 M	133 M	125 M	125 M	125 M	125 M	125 M	113 M	113 M	113 M	113 M	89.3 M	89.3 M	89.3 M	89.3 M	72.8 M	72.8 M	72.8 M	72.8 M	59.6 M	59.6 M	59.6 M	59.6 M	27.3 M	27.3 M	27.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
217 M	27.3 M	120 M

Book Value of other stocks in the Medical devices industry

Issuer	Book Value	Price	% 24h	Market Cap	Country
BioSig Technologies BSGM	-1.42 M	-	37.08 %	$ 85.7 M	USA
GenMark Diagnostics, Inc. GNMK	196 M	-	-	$ 1.77 B	USA
Axonics Modulation Technologies AXNX	570 M	-	-	$ 3.31 B	USA
Lianluo Smart Limited LLIT	272 M	-	24.59 %	$ 44.8 M	China
Xtant Medical Holdings XTNT	43 M	$ 0.55	-2.31 %	$ 73.5 M	USA
Dynatronics Corporation DYNT	3.26 M	-	14.99 %	$ 929 K	USA
Aziyo Biologics AZYO	27.7 M	-	1.37 %	$ 20.5 M	USA
Acutus Medical AFIB	-879 K	-	-26.83 %	$ 2.62 M	USA
Zimmer Biomet Holdings ZBH	12.5 B	$ 88.57	-0.65 %	$ 18 B	USA
Allied Healthcare Products AHPI	19.7 M	-	3.58 %	$ 2.21 M	USA
Obalon Therapeutics, Inc. OBLN	25.5 M	-	-5.86 %	$ 30.6 M	USA
Alphatec Holdings ATEC	791 M	$ 10.93	-5.12 %	$ 1.64 B	USA
Conformis CFMS	54.2 M	-	-	$ 16.4 M	USA
Accuray Incorporated ARAY	81.2 M	$ 0.4	4.21 %	$ 41.1 M	USA
Cardiovascular Systems CSII	249 M	-	0.15 %	$ 844 M	USA
Second Sight Medical Products EYES	15.7 M	-	-0.97 %	$ 54.4 M	USA
Apollo Endosurgery APEN	32.6 M	-	-	$ 475 M	USA
Avinger AVGR	-6.2 M	-	-20.74 %	$ 369 K	USA
CryoLife, Inc. CRY	58.1 M	-	-4.14 %	$ 702 M	USA
CHF Solutions, Inc. CHFS	6.23 M	-	1.15 %	$ 34.5 M	USA
CONMED Corporation CNMD	1.03 B	$ 34.58	-5.62 %	$ 1.07 B	USA
Soliton, Inc. SOLY	243 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	2.61 B	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	229 M	-	0.03 %	$ 1.58 B	Israel
NanoVibronix NAOV	627 K	-	-	$ 1.08 M	USA
Misonix, Inc. MSON	30.4 M	-	-	$ 462 M	USA
Neovasc NVCN	52.2 M	-	-	$ 111 M	Canada
Intersect ENT, Inc. XENT	550 M	-	-	$ 955 M	USA
Cytosorbents Corporation CTSO	11.1 M	$ 0.59	-1.18 %	$ 32.1 M	USA
Aethlon Medical AEMD	5.12 M	$ 2.15	-5.29 %	$ 3.36 M	USA
Edwards Lifesciences Corporation EW	10.3 B	$ 79.34	-3.36 %	$ 46.4 B	USA
BIOLASE BIOL	1.96 M	-	-13.19 %	$ 166 K	USA
AdaptHealth Corp. AHCO	1.53 B	$ 11.2	-1.84 %	$ 1.51 B	USA
OrthoPediatrics Corp. KIDS	347 M	$ 15.52	-5.08 %	$ 364 M	USA
Invacare Corporation IVC	771 M	-	-	$ 24.7 M	USA
Ra Medical Systems RMED	9.26 M	-	10.0 %	$ 610 K	USA
Myomo MYO	11.4 M	$ 0.7	2.32 %	$ 29.3 M	USA
Penumbra PEN	1.43 B	$ 335.1	-0.39 %	$ 13 B	USA
Inspire Medical Systems INSP	781 M	$ 50.13	-0.63 %	$ 1.47 B	USA
Pulmonx Corporation LUNG	54.1 M	$ 1.17	-5.65 %	$ 47.6 M	USA
Cutera CUTR	-172 M	-	-10.19 %	$ 1.99 M	USA
Eargo EAR	101 M	-	-	$ 10.2 M	USA
NuVasive NUVA	2.22 B	-	-	$ 2.07 B	USA
Nevro Corp. NVRO	231 M	-	-	$ 217 M	USA
Surgalign Holdings SRGA	-15.7 M	-	-32.98 %	$ 1.68 M	USA
STRATA Skin Sciences SSKN	21.8 M	-	-	$ 6.6 M	USA
GBS GBS	2.81 M	-	-0.57 %	$ 7.12 M	USA
AVITA Medical RCEL	-16.6 M	$ 3.82	-1.04 %	$ 106 M	Australia
AxoGen AXGN	129 M	$ 31.28	-3.01 %	$ 1.44 B	USA
Delcath Systems DCTH	111 M	$ 8.97	-1.75 %	$ 321 M	USA